New trial matches cancer drugs to tumor DNA for advanced patients

NCT ID NCT04116541

Recruiting now Disease control Sponsor: Centre Leon Berard Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests targeted cancer drugs in people with advanced solid tumors that have not responded to standard treatments. Participants receive a drug chosen based on the genetic changes in their tumor. The goal is to see if the treatment can stop or shrink the cancer for at least 3 months. About 455 adults will take part across multiple centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer metastatic malignant neoplasm neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT SOLID TUMOR

Contacts and locations

Locations

CHU Strasbourg - Hôpital de Hautepierre
RECRUITING

Strasbourg, 67098, France
Centre Antoine LACASSAGNE
RECRUITING

Nice, 06189, France
Centre François Baclesse
RECRUITING

Caen, 14076, France
Centre Henri Becquerel
NOT_YET_RECRUITING

Rouen, 76038, France
Centre Léon Bérard
RECRUITING

Lyon, 69373, France
Centre Paul Strauss
RECRUITING

Strasbourg, 67033, France
INSTITUT DE CANCEROLOGIE DE L'OUEST Pays de Loire
NOT_YET_RECRUITING

Angers, 49055, France
Institut Bergonié
RECRUITING

Bordeaux, 33076, France
Institut Claudius Regaud
RECRUITING

Toulouse, 31059, France
Institut Curie
NOT_YET_RECRUITING

Paris, 75248, France
Institut Gustave Roussy
RECRUITING

Villejuif, 94805, France
Institut Paoli Calmettes
RECRUITING

Marseille, 13273, France
Institut de Cancérologie de Strasbourg
TERMINATED

Strasbourg, 67033, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.